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Abstract
Lactulose, a synthetic sugar not able to be digested and absorbed by human beings, is widely used to treat
constipation and hepatic encephalopathy clinically. Through fermentation by the bacteria in the gastrointestinal
tract, lactulose can produce considerable amount of hydrogen, which is protective for ischemic stroke as a unique
antioxidant. We propose that lactulose can induce the production of endogenous hydrogen that in turn reduces
oxidative stress and ameliorate the stroke damage in human beings.
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Introduction
Currently stroke is the second leading cause of death in
the Western world, ranking after heart diseases and
before cancer [1], causing 10% of deaths worldwide [2].
It is estimated that stroke could soon be the most com-
mon cause of death worldwide [3]. An ischemic stroke
can be due to ischemia (lack of blood flow) caused by
blockage (thrombosis, arterial embolism), which may
lead to rapidly developing loss of brain functions as a
result of disturbance in the blood supply to the brain
[4]. Stroke can affect patients physically, mentally, emo-
tionally, or a combination of the three and bring heavy
burdens to society.
Ischemia induces production of reactive oxygen spe-
cies (ROS), which can react with and damage a number
of cellular and extracellular elements. Evidence has
accumulated showing that ROS are involved in cerebral
ischemia and reperfusion. During cerebral ischemia, cer-
ebral blood flow was partially or completely cut off in
brain regions supplied by the occluded vessels. Reoxy-
genation due to spontaneous or thrombolytic reperfu-
sion offers oxygen as a substrate for a number of
enzymatic oxidation, constantly generating ROS like
superoxide anion radicals(O2·-) and hydrogen peroxide
(H2O2) [5]. ROS are known to be able to result in
macromolecular damages including lipid peroxidation,
protein oxidation, and DNA oxidation, which result in
ischemic brain injury [6]. Clinically, a number of recent
studies have revealed that stroke and oxidative stress are
closely related and excess oxidative stress may have
deleterious effects on clinical outcome in acute ischemic
stroke [7,8]. Therefore, antioxidants have been consid-
ered in prevention and treatment of stroke and certain
agents with antioxidative effects did have neuroprotec-
tive effects [9].
Molecular hydrogen (H2) serves as a novel inflammation
suppressor
In recent years, experimental evidences have documen-
ted that without influencing other less potent ROS,
important in intracellular signaling, molecular hydrogen
possesses the ability to selectively neutralize ONOO
-
and ￿OH, the most cytotoxic ROS, which can damage
cellular macromolecules aggressively and indiscrimi-
nately. Thus, hydrogen can protect cells from oxidative
stress injuries [10]. Therapeutic effects of hydrogen gas
and hydrogen-rich saline have been experimentally con-
firmed in a number of studies, including hypoxia
[11,12], ischemia-reperfusioni n j u r i e si nv a r i o u st i s s u e s
and organs [13-18], and other injuries related to oxida-
tive stress. Especially in brain ischemia, our previous
research has demonstrated that hydrogen administration
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inhibition of neuronal apoptosis in neonatal hypoxia-
ischemia rat model [19]. Another study reported that
2.1% hydrogen-supplemented room air ventilation
would preserve cerebrovascular reactivity (CR) and brain
morphology after asphyxia/reventilation (A/R) in new-
born pigs [20]. For transient cerebral ischemia, hydrogen
also showed significant protective effects [21]. Several
studies have demonstrated the neuroprotective effects of
molecular hydrogen. Interestingly enough, even for
some chronic neurodegenerative diseases, like the Alz-
heimer’s disease [22] and Parkinson disease [23,24],
hydrogen showed certain protective effects.
As a novel antioxidant, hydrogen possesses a number
of advantages. (1) Due to its high permeability, hydrogen
can easily penetrate biomembranes and diffuse into the
cytosol, mitochondria and nucleus. (2) It is nontoxic to
the organisms, which has been proven by hyperbaric
diving study for decades. (3) Due to its selectivity as an
antioxidant, hydrogen has less impact on other less
active but very important ROS within the cells.
Endogenous hydrogen is effective for alleviating
oxidative stress
For therapeutic purposes, whether inhalation of hydro-
gen gas or injection or drinking of hydrogen-rich saline
have unavoidable inconvenience. Hydrogen gas is highly
flammable and explosive, thus being very dangerous.
The effects of hydrogen-rich saline are not so ideally
maintained. Therefore, frequent administration is
required. Couldn’t it be better if there is a way leading
to persistent hydrogen generation under control? Endo-
genous hydrogen may give a perfect answer.
Early in 1969, a study published in the New England
Journal of Medicine showed that endogenous hydrogen
existed within human beings [25]. Studies have revealed
that bacteria in the large intestine could generate endo-
genous hydrogen through anaerobic metabolism in
human beings and animals [26]. Previously, the biologic
effects of this little amount of hydrogen were often
neglected, because studies have shown that the hydro-
gen level in normal terminal breath is about 5-10 ppm.
However, in patients with lactose intolerance and bac-
terial disorders, the level may reach more than 90 ppm
[27]. Hydrogen concentration has been measured in dif-
ferent organs of normal mice. The results showed that
hydrogen level was very high in the large intestine,
spleen, liver and gastric mucosa [28]. In the liver it
reached to 42 μM, and in the large intestine and spleen
it was even higher. A research on PC12 cells showed
that a concentration of 25 μMo fh y d r o g e ni nt h em e d -
ium would display a significant anti-oxidation effect
[10]. These results indicated that endogenous hydrogen
generated might have important biological effects.
Some of the recent findings further imply the potential
therapeutic effects of endogenous hydrogen. Acarbose,
which inhibits glucose absorption and often causes
abdominal distention in diabetes mellitus treatment,
shows an amazing cardiac protective effect. One of the
main gases generated, which cause the abdominal dis-
tention, is hydrogen [29]. Oral administration of curcu-
min could also promote the production of endogenous
hydrogen, which may be one of the mechanisms for cur-
cumin treatment of some diseases [30]. Moreover, it is
reported that oral administration of bacteria producing
hydrogen gas can prevent Con A-induced hepatitis. And
after antibiotic treatment, the protective effect amazingly
disappeared, indicating that hydrogen produced by
intestinal bacteria was the key for therapeutic effects
[31].
Since hydrogen production in man is primarily depen-
dent on the delivery of ingested, fermentable substrates
to an abundant intestinal flora normally present only in
the colon, identifying an ideal endogenous hydrogen
inducer seems strikingly attractive.
Lactulose is a good option worth considering.
Lactulose mediates hydrogen production and is an ideal
endogenous hydrogen inducer
Lactulose is a synthetic sugar used in the treatment of
constipation [32] and hepatic encephalopathy. It is a dis-
accharide formed from one molecule fructose and one
molecule of galactose and cannot be absorbed by
human bodies but can be digested by bacteria colonizing
within the gastrointestinal tract, especially in the colon.
One of the main byproducts is hydrogen. Oral adminis-
tration of lactulose significantly increases hydrogen pro-
duction [33], which can be detected by hydrogen breath
test, introduced several decades ago as a diagnostic test
for small bowel bacterial overgrowth [34].
In 2004, it was observed that lactulose had some pro-
tective effects on DSS-induced colitis [35]. Interestingly
e n o u g h ,i td e m o n s t r a t e dt h a tl a c t u l o s er e d u c e dt h e
severity of colonic lesions induced by DSS treatment in
a dose-dependent manner, the effect at 100 mg/kg being
more potent than that of 5-ASA. Lactulose also pre-
vented the colon shortening and ameliorated the histo-
logical inflammation, together with significant
attenuation of the increase in MPO activity as well as
lipid peroxidation following DSS treatment. Lactulose
lowered oxidative stress state. Hydrogen may be the key.
A study showed that 20 g lactulose administration
could increase the exhaled hydrogen nearly to the same
level of exhaled hydrogen as compared to the consump-
tion of 300 ml hydrogen-rich saline and had a longer
maintenance time of hydrogen concentration [32].
Therefore, oral administration of lactulose may be a bet-
ter option in terms of maintenance of the appropriate
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can treat constipation by increasing the water content
and volume of the stools in the bowel, making them
softer and easier to pass. As is known, constipation is
one of the important risk factors for cerebrovascular
accidents and a major complication after stroke.
Hypothesis
Lactulose has been proved effective in ameliorating oxi-
dative stress injuries in DSS-induced mice colitis. Based
on these observations and experiments, we hypothesize
that lactulose may be a novel promising preventive and
therapeutic option for stroke as an indirect antioxidant.
By increasing gastrointestinal tract derived hydrogen, it
may significantly reduce the possibility of stroke and
alleviate ischemia/reperfusion injury after the stroke,
improving the life quality of patients. What’s more, it is
noteworthy that lactulose probably has many other ben-
eficial antioxidant effects on a wide range of aspects,
such as cardiovascular diseases, neurodegenerative dis-
eases et al., which still needs further study.
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